George Perry to Cholinesterase Inhibitors
This is a "connection" page, showing publications George Perry has written about Cholinesterase Inhibitors.
Connection Strength
0.150
-
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks. J Alzheimers Dis. 2015; 44(2):549-60.
Score: 0.112
-
Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev Neurother. 2010 May; 10(5):683-91.
Score: 0.020
-
Current approaches in the treatment of Alzheimer's disease. Biomed Pharmacother. 2008 Apr-May; 62(4):199-207.
Score: 0.017